< Back to search trials

Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365) (*Cohort D only)

  • Clinicaltrials.gov #: NCT02861573
  • Acronym: KEYNOTE-365
  • Tumor Type: Genitourinary
  • Tumor Subtype: Prostate Cancer
  • Tumor Stage: N/A
  • Type of Treatment: